YURLO

What this means for you

Registered since 11 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Aug 2032: the §8 declaration of use).

Record

Serial number

99228564

Registration number

8387795

Mark type

Word mark

Filed

11 Jun 2025

Published for opposition

21 Oct 2025

Registered

11 Aug 2026

Next maintenance filing

§8 declaration of use, due by 11 Aug 2032 (grace period to 11 Feb 2033)

Attorney of record

Leonid Rakitin

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Vaccines

Owner

• AstraZeneca AB, Södertälje, SE
• AstraZeneca AB, Södertälje, SE
• AstraZeneca AB, Södertälje, SE

Prosecution history

• 11 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 11 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
• 06 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 06 Aug 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 06 Aug 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 21 Jul 2026 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
• 15 Apr 2026 — NOTICE OF ALLOWANCE CANCELLED
• 15 Apr 2026 — TEAS DELETE 1(B) BASIS RECEIVED
• 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 21 Oct 2025 — PUBLISHED FOR OPPOSITION
• 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 21 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 21 Sept 2025 — ASSIGNED TO EXAMINER
• 11 Jun 2025 — APPLICATION FILING RECEIPT MAILED